GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of stalled for 11 weeks at 2.5mg and I refuse to panic this time — 15 comments in the full submission. View in context.
-82
c/orforglipron·submitted 1 year ago by u/search_before_post

stalled for 11 weeks at 2.5mg and I refuse to panic this time

Paperbranch of 10 comments

Genuinely asking, not being difficult. Everyone in c/sideeffects repeats that non-peptide is important. I believe it, but I have never seen anyone show why, and when I search I get 23 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true…

Read the full submission and all 15 comments →

This branch

10 comments, started 1 year ago
u/greta_nilsen4 points·1 year ago

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

replysharereportpermalink
u/trialwatch_theoMOD3 points·1 year ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/piotr_bruun4 points·1 year ago

Yeah, small molecule changes the whole game.

replysharereportpermalink
u/viktor_laurent2 points·1 year ago

cite ATTAIN/ACHIEVE arms specifically

replysharereportpermalink
u/discount_math_dm1 point·1 year ago

the non-peptide is whether this actually works long-term

replysharereportpermalink
u/joaquin_trevino1 point·1 year ago

small molecule purity is different testing than peptides

replysharereportpermalink
u/erez_yilmaz1 point·1 year ago

Inter-lab variance on this kind of assay is routinely 1–2 points.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/pancreatitis_scare3 points·1 year ago

cite ATTAIN/ACHIEVE arms specifically

replysharereportpermalink
u/kenji_laurent-31 points·1 year ago

Yeah, small molecule changes the whole game.

replysharereportpermalink
u/reship_roulette2 points·1 year ago

ATTAIN and ACHIEVE are phase 9 trials

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/orforglipron
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/phase_two_peteu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →